Rev Esp Quimioter 2019; 32(Suppl. 2):59-62

Prophylaxis of mould infections  

ESTELA MORENO-GARCÍA, MARIANA CHUMBITA, PEDRO PUERTA-ALCALDE, CELIA CARDOZO, CAROLINA GARCIA-VIDAL

Invasive fungal infection continues to be an important cause of morbidity and mortality in haematological patients. Antifungal prophylaxis in these patients has remarkably increased survival since its introduction. In recent years, new antifungals have been on the rise, being more effective and having less toxicity than previous ones. Nonetheless, the number of patients at risk of fungal infection has also been increasing due to the continuous appearance of new immunosuppressive treatments. As a result of such, we face a changing situation that requires constant updating.

Rev Esp Quimioter 2019; 32(Suppl. 2):59-62 [Full-text PDF]